テキサスにおける頭頸部がんの臨床試験
テキサス内の拠点で、頭頸部がんに関する42件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
- The University of Texas M. D. Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/05更新 · NCT07101432The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- New Experimental Therapeutics - NEXT Oncology, Austin
- Texas Oncology, Bedford
- UT Southwest Simmons Cancer Center, Dallas
- 他2件
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- Site#0102, Houston
- Site #0152, Waco
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06788990A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center - Conroe, Conroe
- University of Texas MD Anderson Cancer Center, Houston
- The University of Texas, MD Anderson Cancer Center - West Houston, Houston
- 他3件
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07090499A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 5, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07085091Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
- The University of Texas M. D. Anderson Cancer Center, Houston
被験者募集中
18歳以上 · 全性別 · 2026/09/25更新 · NCT06667427Intratumoral N17350 in Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07339176A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- MD Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07020117First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
- NEXT Oncology Austin, Austin
- NEXT Oncology - Dallas, Irving
- NEXT Oncology - San Antonio, San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06657222A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
- MD Anderson Cancer Center, Houston
- Site 102 - START San Antonio, San Antonio
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT07462377A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC
- Site US074, Tyler
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/08更新 · NCT07807163Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT
- University of Texas Southwestern, Dallas
被験者募集中
18歳以上 · 全性別 · 2026/09/04更新 · NCT05442957A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The University of Texas, MD Anderson Cancer Center, Houston
- UT Health Mays Cancer Center, San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT05592626IDOV-Immune for Advanced Solid Tumors
- MD Anderson Cancer Center, Houston
- South Texas Accelerated Research Therapeutics, San Antonio
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/05更新 · NCT06910657Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- The University of Texas Health Science Center at Tyler, Tyler
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT04198766Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
- MD Anderson Cancer Center, Houston
被験者募集中第2相
全年齢 · 女性 · 2026/07/24更新 · NCT06912763Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
- M D Anderson Cancer Center, Houston
被験者募集中
18歳以上 · 全性別 · 2026/07/15更新 · NCT01365169First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- University of Texas Southwestern, Dallas
- University of Texas MD Anderson Cancer Center, Houston
- 他1件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT05768139Lead-212 PSV359 Therapy for Patients With Solid Tumors
- MD Anderson Cancer Center, Houston
被験者募集中第1/2相
18歳〜90歳 · 全性別 · 2026/07/06更新 · NCT06710756Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations
- UTHealth Houston Cizik School of Nursing, Houston
被験者募集中
18歳以上 · 全性別 · 2026/07/06更新 · NCT06030011Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- JPS Health Network, Forth Worth
- Baylor Scott and White Biorepository, Temple
被験者募集中観察研究
18歳以上 · 全性別 · 2026/06/29更新 · NCT07327489Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
- START, San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/23更新 · NCT06993844A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- UT Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/05/27更新 · NCT03093116A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- GSK Investigational Site, Dallas
- GSK Investigational Site, Fort Worth
- GSK Investigational Site, San Antonio
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/26更新 · NCT06256588Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- MD Anderson Cancer Center, Houston
- NEXT Oncology, San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/06更新 · NCT06239194Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy
- UT Southwestern Medical Center, Dallas
被験者募集中第2相
18歳〜99歳 · 全性別 · 2026/04/17更新 · NCT06477692Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
- M D Anderson Cancer Center, Houston
被験者募集中
18歳以上 · 全性別 · 2026/04/16更新 · NCT03145077Web-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping Strategies
- Texas Health Care-Otolaryngology and Plastic Surgery Associates, Fort Worth
- M D Anderson Cancer Center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/15更新 · NCT04003051A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
- University of Texas Southwestern Medical Center, Dallas
被験者募集中第2相
18歳〜99歳 · 全性別 · 2026/04/14更新 · NCT05576974The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Md Anderson Cancer Center, Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/05更新 · NCT04075305Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy
- The University of Texas Southwestern Medical Center, Dallas
- Baylor College of Medicine, Houston
被験者募集中
18歳〜85歳 · 全性別 · 2026/02/12更新 · NCT07405645cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Elligo Health Research, Inc., Austin
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881Sample Collection for Ongoing Research and Product Evaluation Study
- Natera, Inc., Austin
被験者募集中観察研究
18歳以上 · 全性別 · 2026/01/15更新 · NCT07318051Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
- Baylor College of Medicine, Houston
被験者募集中
18歳以上 · 全性別 · 2025/12/11更新 · NCT05793151VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- The University of Texas MD Anderson Cancer Center (site 127), Houston
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2025/12/11更新 · NCT03556228SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Dallas
- Massive Bio SYNERGY-AI site, Houston
- Massive Bio SYNERGY-AI site, Temple
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- Mary Crowley Cancer Research, Dallas
- University of Texas Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/09/24更新 · NCT05941507Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- MD Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2025/08/15更新 · NCT04429542ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。